NBAF Project Joint Venture Team Site
On September 18, 2009, the Department of Homeland Security announced the award of a contract for the preconstruction phase services of the proposed National Bio and Agro Defense Facility (NBAF). This contract will allow the future construction manager to participate during the current design phase as a member of the project core team to perform design and constructability reviews.
The Department selected the joint venture team of McCarthy Mortenson as the construction firm to complete the preconstruction phase services and construction phase services required for successful completion of the project. McCarthy’s corporate headquarters office is located in St. Louis, MO and has a local office in Leawood, KS. Mortenson has local offices in Manhattan, KS and is the largest general contractor in that area. McCarthy Mortenson was awarded the contract through a competitive process based on their expertise in constructing biocontainment labs. The contract includes phased options to award future construction tasks to the firm for the duration of the NBAF development process as part of the Construction Manager as Constructor (CMc) acquisition approach, successfully used on DHS’s National BioDefense Analysis & Countermeasures Center (NBACC) project.
NBAF Mission and Research
NBAF will be a state-of-the-art biocontainment facility for the study of foreign animal, emerging and zoonotic (transmitted from animals to humans) diseases that threaten the U.S. animal agriculture and public health. NBAF will provide and strengthen our nation with critical capabilities to conduct research, develop vaccines and other countermeasures, and train veterinarians in preparedness and response against these diseases. For the past 50 years, the Plum Island Animal Disease Center (PIADC) has served our nation as the primary facility to conduct this research. However, PIADC is nearing the end of its life-cycle and needs to be replaced in order to meet U.S. research requirements and ensure the timely development of countermeasures in the event of an outbreak. NBAF meets that need and will serve as a replacement for the PIADC facility. Strategically, NBAF will boast of new and expanded capabilities, specifically, Biosafety Level (BSL) 4 containment for the study of high-consequence diseases affecting large livestock.
Specifically, NBAF will meet its mission by:
- Providing enhanced research capabilities to diagnose foreign animal, emerging and zoonotic diseases in large livestock
- Providing expanded vaccine and countermeasure development capabilities for large livestock
- Replacing and expanding research currently done at the PIADC in New York, and continuing the partnership between the Department and the USDA Animal Research Service (ARS) and Animal and Plant Health Inspection Service (APHIS).
NBAF rests on a strategic partnership between DHS and USDA. These agencies set research priorities based on threats to animal agriculture, and conduct risk assessments, gap analysis and other necessary evaluations to protect our nation from threats to our animal agriculture and public health. Within the facility, DHS and USDA will continue the work of PIADC at NBAF to conduct research, diagnostics, vaccine development and testing, and training in preparedness and response for veterinary and animal agricultural specialists.
The following diseases would be studied at NBAF which would require BSL-3 and BSL-4 laboratory capabilities:
- Nipah Virus
- Hendra Virus
- African Swine Fever
- Rift Valley Fever
- Japanese Encephalitis Virus
- Foot and Mouth Disease
- Classical Swine Fever
- Contagious Bovine Pleuropneumonia